Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kalle Sigfridsson

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Drug Development and Industrial Pharmacy|July 25, 2013
Evaluation of systemic exposure of nanoparticle suspensions subcutaneously administered to mice regarding stabilization, volume, location, concentration and sizeKalle Sigfridsson, Malin Palmer
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 25, 2017
A preformulation evaluation of a photosensitive surface active compound, explaining concentration dependent degradationKalle Sigfridsson, Karin E Carlsson
International Journal of Pharmaceutics|July 28, 2016
Evaluation of preclinical formulations for a poorly water-soluble compoundAnna-Karin Granath, Kalle Sigfridsson
Drug Development and Industrial Pharmacy|July 2, 2019
Nano- and microcrystals of griseofulvin subcutaneously administered to rats resulted in improved bioavailability and sustained releaseKalle Sigfridsson, Hanna Rydberg, Marie Strimfors
Drug Development and Industrial Pharmacy|June 29, 2011
Preformulation evaluation of AZD1305, an oxabispidine intended for oral and intravenous treatmentKalle Sigfridsson, Robert Lundqvist, Kristina Ohlson
Drug Development and Industrial Pharmacy|April 6, 2013
Subcutaneous administration of nano- and microsuspensions of poorly soluble compounds to ratsKalle Sigfridsson, Anders Lundqvist, Marie Strimfors
Drug Development and Industrial Pharmacy|December 18, 2012
Evaluation of exposure properties after injection of nanosuspensions and microsuspenions into the intraperitoneal space in ratsKalle Sigfridsson, Anders Lundqvist, Marie Strimfors
Drug Development and Industrial Pharmacy|March 23, 2011
Co-administration of a nanosuspension of a poorly soluble basic compound and a solution of a proton pump inhibitor--the importance of gastrointestinal pH and solubility for the in vivo exposureKalle Sigfridsson, Anders Lundqvist, Marie Strimfors
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 4, 2018
The crystalline salt form of a selected candidate drug showed photo-, thermal- and humidity induced form transitionsKalle Sigfridsson, Martin Lindsjö, Stefan Paulsson
The Journal of Pharmacy and Pharmacology|July 24, 2024
Case study: cremophor EL-based liquid formulations as simple substitutes for amorphous solid dispersions in early preclinical in vivo studiesKalle Sigfridsson, Xiang Zhang, Antonio Llinas
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Drug Development and Industrial Pharmacy|July 25, 2013
Evaluation of systemic exposure of nanoparticle suspensions subcutaneously administered to mice regarding stabilization, volume, location, concentration and sizeKalle Sigfridsson, Malin Palmer
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 25, 2017
A preformulation evaluation of a photosensitive surface active compound, explaining concentration dependent degradationKalle Sigfridsson, Karin E Carlsson
International Journal of Pharmaceutics|July 28, 2016
Evaluation of preclinical formulations for a poorly water-soluble compoundAnna-Karin Granath, Kalle Sigfridsson
Drug Development and Industrial Pharmacy|July 2, 2019
Nano- and microcrystals of griseofulvin subcutaneously administered to rats resulted in improved bioavailability and sustained releaseKalle Sigfridsson, Hanna Rydberg, Marie Strimfors
Drug Development and Industrial Pharmacy|June 29, 2011
Preformulation evaluation of AZD1305, an oxabispidine intended for oral and intravenous treatmentKalle Sigfridsson, Robert Lundqvist, Kristina Ohlson
Drug Development and Industrial Pharmacy|April 6, 2013
Subcutaneous administration of nano- and microsuspensions of poorly soluble compounds to ratsKalle Sigfridsson, Anders Lundqvist, Marie Strimfors
Drug Development and Industrial Pharmacy|December 18, 2012
Evaluation of exposure properties after injection of nanosuspensions and microsuspenions into the intraperitoneal space in ratsKalle Sigfridsson, Anders Lundqvist, Marie Strimfors
Drug Development and Industrial Pharmacy|March 23, 2011
Co-administration of a nanosuspension of a poorly soluble basic compound and a solution of a proton pump inhibitor--the importance of gastrointestinal pH and solubility for the in vivo exposureKalle Sigfridsson, Anders Lundqvist, Marie Strimfors
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 4, 2018
The crystalline salt form of a selected candidate drug showed photo-, thermal- and humidity induced form transitionsKalle Sigfridsson, Martin Lindsjö, Stefan Paulsson
The Journal of Pharmacy and Pharmacology|July 24, 2024
Case study: cremophor EL-based liquid formulations as simple substitutes for amorphous solid dispersions in early preclinical in vivo studiesKalle Sigfridsson, Xiang Zhang, Antonio Llinas
Pageof 4